Form D/A — Quanta Therapeutics, Inc.
0001891891-26-000002 · filed Jun 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $89,098,282
- Reported amount sold
- $76,192,272
- Minimum investment
- $0
- Investors
- 17
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Quanta Therapeutics, Inc.
- CIK
- 1891891
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- TWO TOWER PLACE, FLOOR 17
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (970) 742-4190
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Perry Nisen · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Maria Fardis · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Rajul Jain · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Ying Huang · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Derek Metzger · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Maha Katabi · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Cameron Pitt · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗